Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2020-07-29 11:06 am Purchase | 13G | Viracta Therapeutics Inc. VIRX | SABBY MANAGEMENT LLC | 10,869,565 11% | 10,869,565 (New Position) | View |
2020-07-24 1:49 pm Purchase | 13G | PULMATRIX INC PAR $0.0001 PULM | SABBY MANAGEMENT LLC | 1,644,502 11% | 646,773 (+64.82%) | View |
2020-07-24 1:15 pm Purchase | 13G | NEXTPLAY TECHNOLOGIES INC NXTP | SABBY MANAGEMENT LLC | 1,000,000 11% | 684,600 (+217.06%) | View |
2020-07-21 09:10 am Purchase | 13G | IMMURON LTD SPONSORED ADR IMRN | SABBY MANAGEMENT LLC | 355,556 11% | 355,556 (New Position) | View |
2020-07-13 09:46 am Purchase | 13G | CASTOR MARITIME INC CTRM | SABBY MANAGEMENT LLC | 7,800,000 11% | 7,800,000 (New Position) | View |
2020-07-08 09:59 am Purchase | 13G | SUPERCOM LTD SHS PAR VALUE SPCB | SABBY MANAGEMENT LLC | 1,480,000 11% | 1,480,000 (New Position) | View |
2020-06-18 10:51 am Purchase | 13G | GLOBUS MARITIME LIMITED COM PA GLBS | SABBY MANAGEMENT LLC | 3,500,000 11% | 3,500,000 (New Position) | View |
2020-06-12 09:49 am Purchase | 13G | NEOVASC INC NO PAR NVCN | SABBY MANAGEMENT LLC | 1,008,828 11% | 1,008,828 (New Position) | View |
2020-06-11 10:16 am Purchase | 13G | CURIS INC PAR $0.01 CRIS | SABBY MANAGEMENT LLC | 3,650,000 11% | 3,650,000 (New Position) | View |
2020-06-09 09:20 am Purchase | 13G | BOXLIGHT CORP COM BOXL | SABBY MANAGEMENT LLC | 1,500,000 11% | 1,500,000 (New Position) | View |
2020-06-03 1:50 pm Purchase | 13G | ALLENA PHARMACEUTICALS COM ALNAQ | SABBY MANAGEMENT LLC | 2,792,683 11% | 2,792,683 (New Position) | View |
2020-06-01 2:07 pm Purchase | 13G | ARCA BIOPHARMA INC PAR $.0 ABIO | SABBY MANAGEMENT LLC | 194,013 11% | 194,013 (New Position) | View |
2020-05-26 2:54 pm Purchase | 13G | BIOLINERX LTD SPONSORED ADR NE BLRX | SABBY MANAGEMENT LLC | 1,142,857 11% | 1,142,857 (New Position) | View |
2020-05-06 11:56 am Purchase | 13G | PURPLE BIOTECH LTD SPONSORED A PPBT | SABBY MANAGEMENT LLC | 8,333,334 11% | 7,357,264 (+753.76%) | View |
2020-05-01 09:25 am Purchase | 13G | PREDICTIVE ONCOLOGY INC PA POAI | SABBY MANAGEMENT LLC | 483,509 11% | 483,509 (New Position) | View |
2020-05-01 08:47 am Purchase | 13G | Vivani Medical Inc. VANI | SABBY MANAGEMENT LLC | 2,200,000 11% | 2,200,000 (New Position) | View |
2020-05-01 08:38 am Purchase | 13G | ACTINIUM PHARMACEUTICALS, INC. ATNM | SABBY MANAGEMENT LLC | 20,095,255 11% | 11,876,667 (+144.51%) | View |
2020-04-20 12:50 pm Purchase | 13G | CHECK-CAP LTD SHS PAR $ CHEK | SABBY MANAGEMENT LLC | 1,000,000 11% | 735,750 (+278.43%) | View |
2020-04-17 12:41 pm Purchase | 13G | PERASO INC PRSO | SABBY MANAGEMENT LLC | 304,500 11% | 304,500 (New Position) | View |
2020-04-16 11:29 am Purchase | 13G | INVIVO THERAPEUTICS HLDGS CORP NVIVQ | SABBY MANAGEMENT LLC | 476,191 11% | 476,191 (New Position) | View |